Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation
Authors
Keywords
-
Journal
JOURNAL OF MICROENCAPSULATION
Volume 35, Issue 1, Pages 102-113
Publisher
Informa UK Limited
Online
2018-01-09
DOI
10.1080/02652048.2018.1425753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part II - Ocular drug-loaded lipid nanoparticles
- (2017) E. Sánchez-López et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen —in vitro, ex vivo and in vivo characterization
- (2016) E. Sánchez-López et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Application of lipid nanoparticles to ocular drug delivery
- (2016) Luigi Battaglia et al. Expert Opinion on Drug Delivery
- Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges
- (2015) Hugo Almeida et al. CURRENT PHARMACEUTICAL DESIGN
- Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration
- (2015) Guadalupe Abrego et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers
- (2015) Noha S. El-Salamouni et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Sustained drug delivery in glaucoma
- (2014) O’Rese J. Knight et al. CURRENT OPINION IN OPHTHALMOLOGY
- Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles
- (2014) Antonio Leonardi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin
- (2012) Mohd. Abul Kalam et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops
- (2012) Mohd. Abul Kalam et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: Improving in vivo ocular bioavailability
- (2012) Rui Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye
- (2011) Joana Araújo et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide
- (2010) Rui Li et al. JOURNAL OF MICROENCAPSULATION
- Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
- (2010) E Gonzalez-Mira et al. NANOTECHNOLOGY
- Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system
- (2009) Mohd. Abul Kalam et al. JOURNAL OF DRUG TARGETING
- Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement
- (2009) Jie Shen et al. NANOTECHNOLOGY
- Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
- (2008) Evren H. Gokce et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct
- (2007) Anthony A. Attama et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started